Phytoresc Laboratories: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Phytoresc Laboratories
Largest movements
- Receivables within one year +€12,124
up €12,124 (+278%), from €4,364 to €16,488
of which Other amounts receivable: +€12,098
- Cash -€5,618
down €5,618 (-32.2%), from €17,440 to €11,822
mainly Receivables within one year (-€12,124) and Deferred charges and accrued income (-€125)
- Tangible fixed assets -€960
down €960 (-33.5%), from €2,864 to €1,904
- Profit (loss) carried forward +€3,793
up €3,793 (+12.4%), from -€30,617 to -€26,824
- Tax, wage and social debts +€1,695
up €1,695 (+26.3%), from €6,437 to €8,132
- Gross operating margin +€27,267
up €27,267 (+428%), from €6,376 to €33,643
- Staff costs +€1,214
up €1,214 (+4.5%), from €26,755 to €27,969
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €24,668 | €30,339 | +€5,671 | +23.0% |
| Fixed assets | 21/28 | €2,864 | €1,904 | -€960 | -33.5% |
| Tangible fixed assets | 22/27 | €2,864 | €1,904 | -€960 | -33.5% |
| Furniture and vehicles | 24 | €2,864 | €1,904 | -€960 | -33.5% |
| Current assets | 29/58 | €21,804 | €28,435 | +€6,631 | +30.4% |
| Amounts receivable within one year | 40/41 | €4,364 | €16,488 | +€12,124 | +278% |
| Trade receivables | 40 | €1,468 | €1,494 | +€26 | +1.8% |
| Other amounts receivable | 41 | €2,896 | €14,994 | +€12,098 | +418% |
| Cash at bank and in hand | 54/58 | €17,440 | €11,822 | -€5,618 | -32.2% |
| Deferred charges and accrued income | 490/1 | - | €125 | +€125 | |
| Total equity and liabilities | 10/49 | €24,668 | €30,339 | +€5,671 | +23.0% |
| Equity | 10/15 | €14,383 | €18,176 | +€3,793 | +26.4% |
| Contributions | 10/11 | €45,000 | €45,000 | = | 0.0% |
| Contributions outside capital | 11 | €45,000 | €45,000 | = | 0.0% |
| Other | 1109/19 | €45,000 | €45,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€30,617 | -€26,824 | +€3,793 | +12.4% |
| Amounts payable | 17/49 | €10,285 | €12,163 | +€1,878 | +18.3% |
| Amounts payable within one year | 42/48 | €10,285 | €12,163 | +€1,878 | +18.3% |
| Trade debts | 44 | €3,848 | €4,031 | +€183 | +4.8% |
| Suppliers | 440/4 | €3,848 | €4,031 | +€183 | +4.8% |
| Taxes, remuneration and social security | 45 | €6,437 | €8,132 | +€1,695 | +26.3% |
| Remuneration and social security | 454/9 | €6,437 | €8,132 | +€1,695 | +26.3% |
| Remuneration, social security and pensions | 62 | €26,755 | €27,969 | +€1,214 | +4.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €960 | €960 | = | 0.0% |
| Other operating charges | 640/8 | €261 | €431 | +€170 | +65.3% |
| Gross operating margin | 9900 | €6,376 | €33,643 | +€27,267 | +428% |
| Operating profit (loss) | 9901 | -€21,599 | €4,284 | +€25,883 | |
| Financial charges | 65/66B | €481 | €491 | +€10 | +2.0% |
| Recurring financial charges | 65 | €481 | €491 | +€10 | +2.0% |
| Profit (loss) for the period before taxes | 9903 | -€22,080 | €3,793 | +€25,873 | |
| Profit (loss) for the period | 9904 | -€22,080 | €3,793 | +€25,873 | |
| Profit (loss) for the period to be appropriated | 9905 | -€22,080 | €3,793 | +€25,873 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.